Fascioliasis hepática humana: Resistencia al tratamiento con triclabendazol

40Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

Human fascioliasis is a parasitic zoonosis that affects the liver of human and herbivorous animals. In chronic cases, its diagnosis is confirmed by direct visualization of parasitic eggs in stool examination, by positive testing for Fasciola hepatica antigens in stools, or by direct observation of parasites by endoscopic retrograde cholangiography or surgery. In acute cases, serological reactions as immunoblothing or detection of parasite antigens in the blood are useful. The treatment of choice is triclabendazole. However, parasite resistance in animals, as well as in man, has been reported to this drug. We report four patients in whom the parasitic infection persisted despite a course of treatment with triclabendazole.

Cite

CITATION STYLE

APA

Gil, L. C., Díaz, A., Rueda, C., Martínez, C., Castillo, D., & Apt, W. (2014). Fascioliasis hepática humana: Resistencia al tratamiento con triclabendazol. Revista Medica de Chile, 142(10), 1330–1333. https://doi.org/10.4067/S0034-98872014001000014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free